Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05517798
Other study ID # MBRUMHS
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date September 1, 2024

Study information

Verified date August 2022
Source Mohammed Bin Rashid University of Medicine and Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Global Burden of Disease Study of 2016 considered oral disease as the most common noncommunicable disease that affected half of the world population throughout their lifetime. Dental caries and periodontal diseases may cause pain and discomfort with severe forms of periodontal diseases causing tooth loss. Periodontal disease and tooth loss were estimated to be one of the ten causes of Years Lived with Disability. The dimensional changes in the alveolar ridge following tooth loss have been extensively investigated in the literature. At six months after tooth loss, a systematic review on bone remodelling showed horizontal and vertical bone loss of 29-63% and 11-22%, respectively. Such bone loss may complicate replacement of missing teeth with dental implants. Dental implant is now a common treatment modality. However, the loss of bone volume may not allow the placement of dental implant in an optimal position and may subsequently jeopardize functional and aesthetic implant outcomes. Therefore, the use of bone replacement graft following tooth extraction, as part of a procedure termed alveolar ridge preservation (ARP), has increasingly becoming a common treatment protocol to optimize dental implant placement in the future. A Cochrane review on ARP has demonstrated that there are no significant differences between the plethora of synthetic or biologically driven grafting materials used to minimize changes in width and height of the extraction sockets. Nevertheless, a regenerative agent, known as enamel matrix derivative (EMD), has gained more attention in regenerative therapy over the last 20 years. Several studies demonstrated its ability to enhance wound healing, induce new attachment and promote bone formation in recession and intrabony defects. Over the last two decades, EMD has been successfully used in the periodontal regeneration of intrabony defects. EMD has the potential to cause early vascularization and support early bone formation, hence, it can be considered as a potential regenerative agent for ARP when used with appropriate carrier material. Moreover, the majority of studies showed that bone substitutes generally performed well in small or contained defects compared with non-grafted sites, but there is lack of information regarding the efficacy of different bone substitute materials in large defects. Short-term follow-up studies of three to six months have also dominated the literature when the main aim of the ARP is to develop a site that optimise long-term implant outcomes. Such aim requires evaluating the long-term performance of dental implants placed in preserved ridges and reporting patient outcomes in well-conducted randomized controlled trial. The aim of the present clinical trial is to evaluate the adjunctive use of EMD in promoting the desired vascularization and bone fill in small and large defects following tooth extraction and report on the long-term implant and patient outcomes.


Description:

A total of 34 participants, attending Dubai Dental Hospital, will be invited to take part in this randomized controlled trial. The participants will be randomly allocated to two equal sized groups (17 per group) using computer-generated numbers: Control group (C): Xenograft (Bio-Oss Collagen, Geistlich Pharma AG, Wolhusen, Switzerland) + resorbable collagen membrane (Bio-Gide; Geistlich Pharma AG, Wolhusen, Switzerland). Test group (T): Xenograft (Bio-Oss Collagen, Geistlich Pharma AG, Switzerland) combined with EMD (Straumann Emdogain, Straumann AG, Basel, Switzerland) + resorbable collagen membrane (Bio-Gide; Geistlich Pharma AG, Wolhusen, Switzerland). The minimally traumatic extraction of the tooth will include raising a full mucoperiosteal flap and sectioning the roots if required. This will allow visual assessment of the socket walls and thorough debridement of the extraction socket. A clinician not involved in the study will then open a sealed opaque envelope and ARP procedure will be carried out by placing either xenograft (Bio-Oss Collagen, Geistlich Pharma AG, Switzerland) alone or combined with EMD (Straumann Emdogain, Straumann AG, Basel, Switzerland). The xenograft (Bio-Oss Collagen, Geistlich Pharma AG, Switzerland) will pre-wetted with blood or saliva prior to applying it to the socket. EMD (Straumann Emdogain, Straumann AG, Basel, Switzerland) will then be placed into the socket. Xenograft will not be mized with EMD outside the oral cavity. In both groups, a resorbable collagen membrane (Bio-Gide; Geistlich Pharma AG, Wolhusen, Switzerland) will be trimmed and adapted to cover the socket. The flaps will then be replaced and sutured with 4/0 polyglycolic acid interrupted and mattress sutures. After six months of healing, CBCT will be utilized in the assessment of the available bone volume and virtual implant treatment planning. A three-dimensional printed surgical stent will be fabricated to aid in implant placement. The implant site will then be prepared according to the surgical protocol outlined in the International Team for Implantology (ITI) consensus conference. This procedure will include raising a mucoperiosteal flap with slightly palatal crestal incision and sulcular incision extending to the adjacent teeth. The osteotomy will be prepared to place a chemically modified, sand-blasted and acid-etched dental implants. In the presence of peri-implant bone defect, simultaneous contour augmentation will be carried out. For all implant surgeries, two-stage protocol will be followed with a re-opening procedure after 12 weeks to place a healing abutment. Prosthodontic Protocol The restorative phase will be carried out in a partial or complete digital workflow. Within 21-28 days of placing the healing abutment, the implant position will be captured using an intraoral optical scanner. Computer-aided design / computer-aided manufacturing (CAD/CAM) will be utilizing the captured digital data to design a screw-retained crown, which will then be milled of monolithic lithium disilicate blanks and bonded to pre-fabricated titanium abutments.


Recruitment information / eligibility

Status Recruiting
Enrollment 34
Est. completion date September 1, 2024
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Aged 18 or over. - Require extraction of anterior or posterior single tooth due to caries, endodontic and prosthetic complications. - The tooth that requires extraction is bordered by two teeth. - Controlled oral hygiene (full-mouth plaque and bleeding scores = 25% at baseline). - Good compliance and commitment to attend follow-up review appointments. - Willing to provide informed consent. Exclusion Criteria: - Localised / generalised periodontitis. - Presence of acute periapical lesion. - Bone metabolic disease and/or taking medications that affect bone metabolism. - Long term use of non-steroidal anti-inflammatory medications. - History of malignancy, radiotherapy or chemotherapy. - Pregnant or lactating women. - Severe bruxism or parafunctional habits. - Large occlusal discrepancies.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Alveolar ridge preservation
Alveolar ridge preservation is a method of decreasing bone resorption following tooth extraction and facilitating prosthetically-driven implant placement

Locations

Country Name City State
United Arab Emirates Dubai Dental Hospital Dubai

Sponsors (1)

Lead Sponsor Collaborator
Mohammed Bin Rashid University of Medicine and Health Sciences

Country where clinical trial is conducted

United Arab Emirates, 

Outcome

Type Measure Description Time frame Safety issue
Primary Implant survival / success rate after one year 'Implant survival' means that implants are still in the mouth at the time of examination 1 year
Primary Patient postoperative experience Postoperative experience means any events occurring after and relating to the procedure 1 week
Primary Implant survival / success rate after two years 'Implant survival' means that implants are still in the mouth at the time of examination 2 years
Primary Implant survival / success rate after three years 'Implant survival' means that implants are still in the mouth at the time of examination 3 years
Secondary Changes in width and height of alveolar ridge Differences in bony dimensions before and after alveolar ridge preservation, meaasured in millimeters using cone beam computed tomography 6 months
Secondary Bone quality Bone quality relates to the degree of bone density present 1 day
Secondary Need for additional bone augmentation Since all the sites had alveolar ridge preservation, we would like to assess whether another bone grafting is required at the time of placing implants. The assessment is YES or NO and it is only assessed ONE TIME ... AT THE TIME OF IMPLANT PLACEMENT 1 day
Secondary Changes in peri-implant marginal bone level Differences in level of bone surrounding the implant 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05553548 - Alveolar Ridge Changes With Biologically Oriented Alveolar Ridge Preservation (BARP) After Tooth Extraction N/A
Active, not recruiting NCT03374813 - Efficacy of MimetikOss in Alveolar Ridge Preservation Previous to Implant Placement N/A
Recruiting NCT06308536 - Application of Concentrated Growth Factors in Alveolar Ridge Preservation N/A
Active, not recruiting NCT05683509 - Alveolar Ridge Preservation With Layered Collagen and Xenograft N/A
Completed NCT02707536 - Influence of Platelet-Rich Fibrin on Post-extraction Alveolar Ridge Healing/Preservation as a Stand-alone or Adjunct to Particulate Graft N/A
Completed NCT03468998 - The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges N/A
Completed NCT03487718 - A 14 Weeks Longitudinal Study to Investigate the Effect of Leukocyte- Platelet Rich Fibrin Plug on the Quality of the Newly Formed Bone in Ridge Preservation Procedure Following a Tooth Extraction. It is a Clinical, Radiographic and Histomorphometric Study. N/A
Not yet recruiting NCT06141239 - 2D/3D Imaging to Analyze the Regeneration Rate of Autologous Bone N/A
Not yet recruiting NCT06435754 - Hard and Soft Tissue Changes Following Vestibular Socket Preservation Versus Ice Cream Cone Technique for Management of Defective Fresh Extraction Sockets in the Esthetic Zone: A Randomized Clinical Trial N/A
Completed NCT04321109 - Alveolar Ridge Preservation Using Collagen Material and Allograft N/A
Terminated NCT04719624 - Novel Porous Bioceramic Material as a Bone Substitute N/A
Completed NCT03043885 - Ridge Preservation With Platelet Rich Fibrin Augmented With Freeze Dried Bone Allograft N/A
Recruiting NCT06275789 - Mix of Demineralized Freeze-Dried Bone Allograft and Deproteinized Bovine Bone Mineral: a Possible Solution for Alveolar Ridge Preservation? N/A
Recruiting NCT04296682 - Impact Of Soft Tissue Manipulation On Dimensional Changes After Posterior Region Extraction. N/A
Recruiting NCT05601531 - Autologous Tooth Root in Ridge Preservation N/A
Completed NCT03422458 - The Impact of Immediate Implant Placement on Alveolar Ridge Preservation Techniques N/A
Completed NCT05419778 - Alveolar Ridge Preservation Procedures
Completed NCT03447795 - Alveolar Ridge Preservation Using Autogenous Tooth Graft Versus Autogenous Demineralized Dentin Graft. N/A
Completed NCT05107141 - Ridge Preservation in Molar Sites Comparing Xenograft Versus Mineralized Freeze-dried Bone Allograft N/A
Active, not recruiting NCT04824235 - Alveolar Ridge Preservation Using Amniotic Chorion Membrane N/A